Bharat Biotech's Covaxin Effective Against Delta+ Covid Variant: Study

Covaxin demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the B.1.617.2 Delta variant.
Source: feedburner feed

Leave a Reply

Your email address will not be published. Required fields are marked *